The Exceptional Patient in Cancer Care

Completed

Conditions studied: Advanced Cancer

In brief

The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state. The primary aim of the study is to develop a detailed description of patients' experience of an exceptional disease course. The secondary aim is to define the content domain for assessment and measurement of exceptional disease course in patients with cancer and identify lessons learned from these exceptional patients that can be a base for future studies to benefit others.

Key facts

Study ID

NCT00543153

Run by

M.D. Anderson Cancer Center

People needed

13

Starts

2007-08-01

Expected to finish

2010-08-01

Last updated by the study team

2012-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Ability to speak and read English with patients residing in the US, ability to speak and read Hebrew with patients residing in Israel.
• Diagnosis of cancer confirmed by pathology.
• Exceptional disease course as identified by patients' physician, in terms of survival and unusual disease course that is appropriately medically documented.
• Consent to participate in this study.

You may not qualify if…

• Inability to understand the intent of the study.
• Medical condition that would preclude participation in an interview session lasting 30-45 minutes.
• Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States
• Tel Aviv University — Tel Aviv, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.